AAA
Affinity Asset Advisors’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-80,000
| Closed | -$5.61M | – | 95 |
|
|
2024
Q1 | $5.61M | Sell |
80,000
-80,000
| -50% | -$5.61M | 0.69% | 37 |
|
|
2023
Q4 | $13.4M | Sell |
160,000
-70,366
| -31% | -$5.87M | 2.44% | 14 |
|
|
2023
Q3 | $6.79M | Buy |
230,366
+105,218
| +84% | +$3.1M | 1.91% | 14 |
|
|
2023
Q2 | $4.08M | Sell |
125,148
-96,315
| -43% | -$3.14M | 1.43% | 21 |
|
|
2023
Q1 | $7.79M | Buy |
221,463
+133,862
| +153% | +$4.71M | 2.57% | 10 |
|
|
2022
Q4 | $4.01M | Buy |
87,601
+22,601
| +35% | +$1.04M | 1.57% | 20 |
|
|
2022
Q3 | $3.15M | Buy |
65,000
+50,000
| +333% | +$2.42M | 0.88% | 27 |
|
|
2022
Q2 | $589K | Buy |
+15,000
| New | +$589K | 0.25% | 32 |
|
|
2022
Q1 | – | Sell |
-145,552
| Closed | -$6.63M | – | 57 |
|
|
2021
Q4 | $6.63M | Buy |
145,552
+20,552
| +16% | +$937K | 2.41% | 14 |
|
|
2021
Q3 | $4.47M | Buy |
125,000
+55,000
| +79% | +$1.97M | 1.13% | 20 |
|
|
2021
Q2 | $1.39M | Buy |
70,000
+30,000
| +75% | +$594K | 0.5% | 40 |
|
|
2021
Q1 | $930K | Sell |
40,000
-30,000
| -43% | -$698K | 0.32% | 40 |
|
|
2020
Q4 | $1.46M | Buy |
+70,000
| New | +$1.46M | 0.77% | 29 |
|